| For: | Hetta HF, Ahmed R, Ramadan YN, Fathy H, Khorshid M, Mabrouk MM, Hashem M. Gut virome: New key players in the pathogenesis of inflammatory bowel disease. World J Methodol 2025; 15(2): 92592 [PMID: 40548227 DOI: 10.5662/wjm.v15.i2.92592] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i2/92592.htm |
| Number | Citing Articles |
| 1 |
Xiao-Long Li, Mueen Megdadi, Humair S Quadri. Interaction between gut virome and microbiota on inflammatory bowel disease. World Journal of Methodology 2025; 15(3): 100332 doi: 10.5662/wjm.v15.i3.100332
|
| 2 |
Sumanpreet Kaur, Raman Thakur. Gut microbiota and inflammatory bowel disease: mechanisms, clinical implications, and future directions. Molecular Biology Reports 2026; 53(1) doi: 10.1007/s11033-025-11195-7
|
| 3 |
Yasmin N. Ramadan, Saleh F. Alqifari, Khaled Alshehri, Amirah Alhowiti, Hyder Mirghani, Tariq Alrasheed, Faisal Aljohani, Abdulaziz Alghamdi, Helal F. Hetta. Microbiome Gut-Brain-Axis: Impact on Brain Development and Mental Health. Molecular Neurobiology 2025; 62(8): 10813 doi: 10.1007/s12035-025-04846-0
|
| 4 |
Lie Zheng, Sheng-Lei Duan, Kai Wang. Research progress concerning the involvement of the intestinal microbiota in the occurrence and development of inflammatory bowel disease. World Journal of Gastroenterology 2025; 31(42): 113170 doi: 10.3748/wjg.v31.i42.113170
|
| 5 |
Rahat Khatoon Khokhar, Abdulqadir J Nashwan. Gut virome and its emerging role in inflammatory bowel disease. World Journal of Methodology 2025; 15(3): 100534 doi: 10.5662/wjm.v15.i3.100534
|
| 6 |
Ahmed Aljabri, Ghareb M. Soliman, Yasmin N. Ramadan, Mohammed A. Medhat, Helal F. Hetta. Biosimilars versus biological therapy in inflammatory bowel disease: challenges and targeting strategies using drug delivery systems. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01558-6
|
